Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.18 -0.79 (-7.20%)
At close: Oct 1, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Other financing activities (2015 - 2026)

Updated

Zevra Therapeutics (ZVRA) reported Other financing activities of -$1.15 million for Q2 2026.

Analysis

Zevra Therapeutics (ZVRA) Other financing activities (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Zevra Therapeutics' Other financing activities came in at $1.49 million; for FY2024, it came in at $2.09 million.

  • Other financing activities has a five-year compound annual growth rate of 47.5% (FY2019 to FY2024).
  • By year, Other financing activities came in at $2.88 million in FY2021 and $34,000 in FY2020 (-88.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Other financing activities in data going back to Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Zevra Therapeutics 650.98 Mn -161.73 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.15 Mn
Mar 31, 2026 2.64 Mn
Mar 31, 2021 2.88 Mn
Mar 31, 2020 34,000.00
Jun 30, 2017 24,000.00
Mar 31, 2017 26,000.00
Dec 31, 2016 124,000.00
Dec 31, 2015 -929,000.00
Sep 30, 2015 576,000.00
API Access

Zevra Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY